ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,487.03
0.25%
Dow Jones
38,834.86
0.15%
US Dollar vs MXN
18.4352
0.01%
Brent Oil
84.605
-0.11%
Bitcoin
65,339.60
0.57%
Registration Strip Icon for monitor Monitoree múltiples cotizaciones en tiempo real de los principales intercambios, como la Bolsa de Valores de Londres, NASDAQ, NYSE, AMEX, Bovespa y más.
Regístrate
Símbolo desconocido
Fecha:
Ordernar por:
FechaHoraFuenteTítuloSímboloCompañía
20/06/202400:30GlobeNewswire Inc.Sampo plc’s share buybacks 19 June 2024
20/06/202400:30GlobeNewswire Inc.OSE Immunotherapeutics présente des données précliniques sur sa plateforme ARNm thérapeutique dans le traitement des maladies auto-immunes et inflammatoires au congrès annuel FOCIS, San Francisco (18 – 21 juin)TG:6OPOSE Immunotherapeutics
20/06/202400:30Business WireSensorion Announces Upcoming Presentation of Promising SENS-401 Results at the Next International Conference on Cochlear Implants and Other Implantable TechnologiesEU:ALSENSensorion
20/06/202400:30GlobeNewswire Inc.BGHL (GBP): NAV(s)LSE:BGHSBoussard & Gavaudan Holding Limited
20/06/202400:30GlobeNewswire Inc.OSE Immunotherapeutics Presents Preclinical Data on mRNA Therapeutic Platform for the Treatment of Inflammatory and Autoimmune Disorders at the FOCIS Annual Meeting, San Francisco (June 18 – 21)EU:OSEOSE Immunotherapeutics
20/06/202400:30GlobeNewswire Inc.BGHL (EUR): NAV(s)EU:BGHLBoussard And Gavaudan Holding Limited
20/06/202400:30Business WireSensorion annonce la présentation de résultats prometteurs du SENS-401 lors de la prochaine Conférence Internationale sur les Implants Cochléaires et autres Technologies ImplantablesEU:ALSENSensorion
20/06/202400:21Alliance NewsAlliance NewsTOP NEWS: China's central bank leaves loan prime rates unmoved
20/06/202400:15GlobeNewswire Inc.Basilea partners oncology drug candidate lisavanbulin with Glioblastoma Foundation
20/06/202400:00NEWSBTCIntoTheBlock Reveals Fact About Current Bitcoin Situation Analysts Are Puzzled ByCOIN:DOGEUSDDogecoin
20/06/202400:00Business WireMon Courtier Energie Groupe Announces the Approval of All Resolutions Supported by the Board of Directors at its Annual General MeetingEU:ALMCEMon Courtier Energie Groupe SA
20/06/202400:00GlobeNewswire Inc.Avextra AG and SynQube GmbH announce a Strategic Partnership in Drug Development with Cannabinoids and other Psychotropic Substances
20/06/202400:00GlobeNewswire Inc.Start of Day Message
20/06/202400:00Business WireMon courtier énergie groupe annonce l’approbation de l’ensemble des résolutions soutenues par le Conseil d’administration lors de son assemblée généraleEU:ALMCEMon Courtier Energie Groupe SA
20/06/202400:00GlobeNewswire Inc.Technip Energies awarded a significant contract for IOCL’s grassroots naphtha cracking unit at Paradip in IndiaEU:TETechnip Energies NV
20/06/202400:00Business WireDassault Systèmes’ 3DEXPERIENCE Platform on the Cloud Selected by Mahindra & Mahindra as It Accelerates Its Digital TransformationNASDAQ:DSYBig Tree Cloud Holdings Limited
20/06/202400:00GlobeNewswire Inc.Avextra und SynQube GmbH geben eine strategische Partnerschaft in der Arzneimittelentwicklung mit Cannabinoiden und anderen psychotropen Substanzen bekannt
20/06/202400:00Business WireBoston Partners Global Long/Short Fund Announces Transfer to FundRock Platform and Share Class Opportunity
20/06/202400:00GlobeNewswire Inc.Nykode Therapeutics Announces Updates on its Inverse Vaccine Platform at FOCIS 2024 Meeting
20/06/202400:00PR Newswire (US)Electronic Shelf Label Market Size to Reach $7.53 Billion, With a CAGR of 18.3% by 2034: Fact.MR Report
19/06/202423:51Alliance NewsAlliance NewsNorth Korea, Russia in defence deal; Kim pledges support on Ukraine
19/06/202423:50Alliance NewsAlliance NewsEamon Ryan resignation to not destabilise Irish government - PM Harris
19/06/202423:50Alliance NewsAlliance NewsSinn Fein president has "huge optimism" ahead of UK general election
19/06/202423:50Alliance NewsAlliance NewsTaoiseach Harris says Irish unity a "political aspiration"
19/06/202423:50Alliance NewsAlliance NewsSinn Fein "actively preparing" for Irish general election
19/06/202423:50Alliance NewsAlliance NewsYouGov projects UK Tories to slump to "lowest seat tally" in history
19/06/202423:49GlobeNewswire Inc.GPS Capital Markets Enters into Agreement to be Acquired by Corpay
19/06/202423:46Alliance NewsAlliance NewsGLOBAL BRIEFING: China rates unchanged; Bank of England ahead
19/06/202423:37PR Newswire (Canada)WestJet and AMFA mutually agree to return to the bargaining table, preventing further network cancellations
19/06/202423:36GlobeNewswire Inc.OKX to Become First in CeFi to Launch AI-Powered Automated Trading Platform, Celebrates with 'Smart Trading Super League' Campaign Featuring 150k USDT in Prizes

Su Consulta Reciente

BIT
I05617
Banca IMI
EU
SGAD1
Euronext G AXA 010622 De...
LSE
71QG
Sunderland 6.38
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

México
Empresa
Negocios
Popular
Obtener la aplicación
App Store
Google Play

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados